The Baylor College of Medicine and diagnostics company Miraca Holdings have reportedly formed a joint venture—Baylor Miraca Genetics Laboratories—that “is expected to fully support the academic mission of the college’s department of molecular and human genetics.” With an initial workforce of 225 based in Houston, Texas, the joint venture aims to expand Baylor’s clinical genetics testing program “while ensuring the quality of diagnostics to patients and health[-]care providers on an international level.” Miraca, which is headquartered in Tokyo, provides in vitro diagnostics, clinical laboratory testing and other health-care services and products through its subsidiaries, including one located in Irving, Texas. Baylor CEO and Executive Dean Paul Klotman said, “What makes this venture so beneficial to our patients and community is that it pairs the academic leadership and innovation of a highly ranked Baylor program with the business acumen of a well-run, well-recognized strategic partner.” See Baylor College of Medicine News Release, October 31, 2014.